CTLA4 and melanoma: Drugs that target programmed cell death, including protein 1(PD1) and Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), have been effective in treatment of not only melanoma, but also other forms of lung cancers and Hodgkin lymphoma.